(7) Approaches to glycemic treatment.

{"article_title":"(7) Approaches to glycemic treatment.","author":"","journal_title":"Diabetes care","issn":"1935-5548","isbn":"","publication_date":"2023 Jan-Mar","volume":"38 Suppl","issue":"","first_page":"S41","page_count":"","accession_number":"25537707","doi":"10.2337\/dc15-S010","publisher":"American Diabetes Association","doctype":"Journal Article","subjects":"Diabetes Mellitus, Type 1 drug therapy; Diabetes Mellitus, Type 2 drug therapy; Hypoglycemic Agents therapeutic use; Blood Glucose; Dipeptidyl-Peptidase IV Inhibitors therapeutic use; Glucagon-Like Peptide 1 agonists; Glycated Hemoglobin; Humans; Insulin therapeutic use; Insulin Infusion Systems; Metformin therapeutic use; Sodium-Glucose Transport Proteins antagonists & inhibitors; Sulfonylurea Compounds therapeutic use","interest_area":["Endocrinology"," Internal Medicine"],"abstract":"","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=25537707&authtype=shib&custid=ns346513&group=main&profile=eds","isPdfLink":true,"isSAML":false,"additionalInfo":{"Corporate_Authors":"American Diabetes Association","Journal_Info":"Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE","Publication_Type":"Journal Article; Practice Guideline","Published_Date":"2015-01-01","Source":"Diabetes care [Diabetes Care] 2015 Jan; Vol. 38 Suppl, pp. S41-8.","Languages":"English","Electronic_ISSN":"1935-5548","MeSH_Terms":"Diabetes Mellitus, Type 1\/*drug therapy , Diabetes Mellitus, Type 2\/*drug therapy , Hypoglycemic Agents\/*therapeutic use, Blood Glucose ; Dipeptidyl-Peptidase IV Inhibitors\/therapeutic use ; Glucagon-Like Peptide 1\/agonists ; Glycated Hemoglobin ; Humans ; Insulin\/therapeutic use ; Insulin Infusion Systems ; Metformin\/therapeutic use ; Sodium-Glucose Transport Proteins\/antagonists & inhibitors ; Sulfonylurea Compounds\/therapeutic use","Subjects":"Blood Glucose, Dipeptidyl-Peptidase IV Inhibitors therapeutic use, Glucagon-Like Peptide 1 agonists, Glycated Hemoglobin, Humans, Insulin therapeutic use, Insulin Infusion Systems, Metformin therapeutic use, Sodium-Glucose Transport Proteins antagonists & inhibitors, Sulfonylurea Compounds therapeutic use, Diabetes Mellitus, Type 1 drug therapy, Diabetes Mellitus, Type 2 drug therapy, Hypoglycemic Agents therapeutic use","Title_Abbreviations":"Diabetes care","Volume":"38 Suppl"},"header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"25537707","RelevancyScore":"778","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"778.456298828125"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=25537707&authtype=shib&custid=ns346513&group=main&profile=eds","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=25537707&authtype=shib&custid=ns346513&group=main&profile=eds"}